Formerly CEO of BGEO Group since 2011, joined as CFO of Bank of Georgia in 2004. Mr Gilauri was appointed Chairman of the Bank in September 2015, having previously served as CEO of the Bank since May 2006. Prior, he was EBRD (European Bank for Reconstruction and Development) banker. Over the last decade, Irakli’s leadership has been instrumental in creating major players in a number of Georgian industries, including banking, healthcare, utilities and energy, real estate, insurance and wine. Holds an MS in banking from CASS Business School.
Irakli GilauriChairman and Chief Executive
David MorrisonSenior Non-Executive Director
David Morrison was appointed as the Senior Independent Non-Executive Director of the Company on 24 February 2018. David Morrison also serves as the Chairman of the Company’s Audit Committee and as a member of the Company’s Investment and Nomination committees.
Mr Morrison is also a Non-Executive Director of Georgia Healthcare Group PLC and a member of the Supervisory Board of JSC Georgia Healthcare Group PLC. Mr Morrison previously served as the Senior Independent Non-Executive Director of BGEO Group PLC from October 2011 until May 2018, which included positions of Chairman of Audit Committee and a member of Remuneration and Nomination Committees. Mr Morrison is a member of the New York bar and worked for 28 years at Sullivan & Cromwell LLP until he withdrew from the firm in 2007 to pursue other interests. At Sullivan & Cromwell, he served as Managing Partner of the firm’s Continental European offices. His practice focused on advising public companies in a transactional context, including capital raisings, IPOs and mergers and acquisitions. Mr Morrison is the author of several publications on securities law-related topics, and has been recognised as a leading lawyer in Germany and France. In 2008, Mr Morrison turned his attention to nature protection financing. He became the Founding CEO of the Caucasus Nature Fund (CNF), a charitable trust fund dedicated to nature conservation in Georgia, Armenia and Azerbaijan. He resigned as CEO in March 2016 and now serves on the Board of Directors of CNF, as well as on the boards of two new conservation trusts he helped to create in 2015 and 2016. Mr Morrison received his undergraduate degree from Yale College, received his law degree from the University of California, Los Angeles, and was a Fulbright scholar at the University of Frankfurt.
Kim BradleyNon-Executive Director
Kim Bradley was appointed as an Independent Non-Executive Director of the Company on 24 February 2018. He also serves on the Remuneration and Nomination committees, and as Chairman of the Investment Committee.
Mr Bradley previously served as an Independent Non-Executive Director of BGEO Group PLC from December 2013 until May 2018. Mr Bradley served as Chairman of BGEO Group PLC’s Risk Committee and as a member of BGEO Group PLC’s Audit and Nomination Committees. Mr Bradley retired from Goldman Sachs in early 2013, following 15 years as a professional in the Real Estate Principal Investments and Realty Management divisions, where he focused on investment in both European real estate and distressed debt. In addition to his investment activities, Mr Bradley led Goldman Sachs’ asset management affiliates in France, Italy and Germany, where he was involved in financial and tax auditors as well as the management of internal audit activities. He has also served as President of Societa Gestione Crediti, a member of the Board of Directors of Capitalia Service Joint Venture in Italy and Chairman of the Shareholders Board at Archon Capital Bank Deutschland in Germany. Prior to Goldman Sachs, he served as a Senior Executive at GE Capital for seven years in both the United States and Europe, where his activities included real estate workouts and restructuring, as well as acquisitions. Prior to GE Capital, Mr Bradley held senior executive positions at Manufacturers Hanover Trust (now part of JP Morgan) and Dollar Dry Dock Bank. He has also served as a Peace Corps volunteer and as a consultant with the US Agency for International Development in Cameroon. Mr Bradley serves as a director of a mental health charity, Gould Farm. Mr Bradley holds an MA in International Affairs from the Columbia University School of International Affairs and an undergraduate degree in English Literature from the University of Arizona.
Massimo Gesua’ sive SalvadoriNon-Executive Director
Massimo Gesua’ sive Salvadori was appointed as an Independent Non- Executive Director of the Company on 24 February 2018. He also serves as a member of the Company’s Investment, Nomination and Audit committees.
Mr. Gesua’ sive Salvadori is a bank analyst covering banking stocks globally. He works for Odey asset management, a London based hedge fund, which he joined in 2011. His professional focus consists of: formulating investment recommendations; assessing potential risks and the balance between potential risks and rewards; developing investment themes; understanding the thinking of management teams and regulators; linking macro themes to individual investment opportunities. Prior to working as a buy side analyst, Mr. Gesua’ sive Salvadori worked as a management consultant at the London office of McKinsey and Co. between 2002 and 2011. He specialised in financial services and served clients across different geographies in developed and emerging markets. Mr. Gesua’ sive Salvadori belonged to the banking strategy practice. Mr. Gesua’ sive Salvadori, a native of Venice, obtained an M.Phil. and a Ph.D. from Oxford University, where he attended St. Antony’s College. He graduated with a B.Sc. in Economics from Warwick University. He attended the United World College of the Adriatic in Duino. His postgraduate studies were funded through scholarships by the Foreign and Commonwealth Office, the Economic Research council, the Fondazione Einaudi and the Ente Einaudi.
William HuyettNon-Executive Director
William Huyett was appointed as a Independent Non-Executive Director of the Company on 24 February 2018. He also serves as the Chairman of the Company’s Remuneration Committee and as a member of the Company’s Investment and Nomination committees.
Mr Huyett was appointed as a Non-Executive Director of Georgia Healthcare Group PLC on 18 June 2017 and serves as a member of the Clinical Quality and Safety Committee. He also serves as a member of the Supervisory Board of JSC Georgia Healthcare Group and on its Clinical and Safety Committee. Mr Huyett is a Director Emeritus of McKinsey and Company, Inc. During his 28-year career there, he served clients in health care and other technology-intensive industries. He currently serves on the boards of Rockefeller University (Member of the Technology Transfer committee), the University of Virginia Darden School Foundation (Chair of Nominating and Governance), the National Parks Conservation Association, and the Concord Museum, where he serves as Treasurer. He is Vice-Chair of the Board of the Greater Boston YMCA and was recently appointed as Chief Operating Officer of Ironwood Pharmaceuticals. He recently retired from the boards of McKinsey and Company (where he chaired the Finance Committee), and the Marine Biological Laboratory (Woods Hole), where he served as Vice-Chair. Prior to joining McKinsey, Mr. Huyett held a variety of line management positions in the automation industry with Rockwell/Allen-Bradley. Mr Huyett earned a BS in Electrical Engineering and an MBA from the University of Virginia.
Caroline BrownNon-Executive Director
Caroline Brown was appointed as in Independent Non-Executive Director of the Company on 24 February 2018. She also serves as a member of the Investment, Nomination and Audit committees.
Dr Brown became an advisor to the Board of Georgia Healthcare Group PLC on 24 February 2018. Dr Brown has managed divisions of FTSE100 groups and AIM businesses with international industrial and technology operations and has worked as a corporate finance adviser to governments and corporations with Merrill Lynch, UBS and HSBC. Dr Brown has chaired audit committees of listed companies for the past 15 years and is a Fellow of the Chartered Institute of Management Accountants. Dr Brown holds a first-class degree and PhD in Natural Sciences from the University of Cambridge and a Masters of Business Administration from the Cass Business School, University of London. Dr Brown currently serves as an independent Non-Executive Director, and audit chair on the boards of several London quoted companies including Luceco plc, Hydrodec Group plc and Earthport plc and serves on the MBA Advisory Board of the Cass Business School, University of London.
Jyrki TalvitieNon-Executive Director
Jyrki Talvitie was appointed as in Independent Non-Executive Director of the Company on 24 February 2018. He also serves as the Chairman of the Company’s Nomination Committee and as a member of the Company’s Investment and Remuneration committees.
Mr Talvitie has worked in the financial industry for 28 years in banks as well as on both the buy and sell side of the markets. Prior to joining the Board, Mr Talvitie worked in Moscow for 14 years, his latest position being in charge of Strategic Partners and Investors at Sberbank, the largest bank in Russia and top 15 in the world. Before Sberbank Mr Talvitie was a Board Member at Russian Direct Investment Fund, Head of Investor Relations at VTB Bank and established and ran the Russian operations of East Capital, a Swedish Private Equity and Asset Management company, while also managing a Financials Fund. Prior to moving to Russia in 2003, Mr Talvitie worked for BNP Paribas in Paris, Bank of New York in London and Moscow as well as several Nordic banks both in Helsinki and Moscow. Mr Talvitie has extensive board experience, having served on over 10 boards of both public and private companies in Georgia, Finland, Russia, Kazachstan and Ukraine. Mr Talvitie holds an Executive MBA from London Business School as well as a Masters of Law from Helsinki University. Mr Talvitie also holds a Diploma in Company Direction from the Institute of Directors in London.